// App-Quantinova.ai

ABS176 : REAL‐WORLD EFFICACY OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH SEVERE HAEMOPHILIA A WITHOUT INHIBITORS: A REPORT FROM THE UK HAEMOPHILIA CENTRE DOCTORS’ ORGANISATION

Researchers

Presenter

  • C. Wall

Principal Investigators

  • H. Xiang

  • B. Palmer

  • P. W. Collins

  • D. Stephensen

  • M. Scott

  • E. Chalmers

  • P. Chowdary

  • G. W. Hall

  • R. Liesner

  • D. P. Hart

  • S. Shapiro

  • K. Talks

  • S. Fletcher

  • C. R. Hay

Medical Centers

  • Manchester Royal Infirmary

  • UK National Haemophilia Database, Manchester, United Kingdom

  • School of Medicine, Cardiff University, Cardiff

  • Haemophilia Centre, Kent and Canterbury Hospital, Canterbury

  • Manchester Haemophilia Centre, Manchester Royal Infirmary, Manchester

  • Royal Hospital for Sick Children, Glasgow

  • Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London, UK

  • Children’s Haematology and Oncology, John Radcliffe Hospital, Oxford

  • Great Ormond Street Haemophilia Centre, Great Ormond Street Hospital

  • Royal London Haemophilia Centre, Barts and The London School of Medicine, London

  • NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford

  • Newcastle Haemophilia Centre, Royal Victoria Infirmary, Newcastle‐upon‐Tyne

  • Oxford Haemophilia and Thrombosis Centre, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved